On August 13th, Remegen (688331.SH/09995.HK) announced that its global first-in-class BLyS (BAFF)/APRIL dual-target fusion protein drug, Telitacicept, met the primary endpoint in its Phase III ...

While Vor provided no details on the results, the company is now evaluating a global trial of the drug in the chronic immune ...

The China-based phase 3 trial of telitacicept in primary Sjögren's syndrome (pSS) met its primary endpoint, which focused on ...

Vor Bio shares climb as RemeGen's Phase 3 study in China shows telitacicept improves disease activity in primary Sjögren's ...

Venus Williams is back on the professional tennis tour at age 45 and will be returning to the U.S. Open next week for her ...

Sjögren, who is currently head coach of Hammarby in Sweden’s top women’s flight, will join the club in January.

The Chicago Stars have named former Norway women’s national team coach Martin Sjögren as the National Women’s Soccer League club’s new head coach. Sjögren will join the Stars starting with ...

The questionable resume, and relaxed timeline of Sjögren's hiring leave more questions than answers around Stars' future ...